These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9531450)

  • 1. Visceral orthostatic hypotension in patients with severe autonomic dysfunction.
    Terazaki H; Ando Y; Yamashita T; Obayashi K; Nakamura K; Nakamura M; Yoshimatsu S; Suga M; Uchino M; Ando M
    J Auton Nerv Syst; 1998 Jan; 68(1-2):101-8. PubMed ID: 9531450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
    Mathias CJ; Senard JM; Braune S; Watson L; Aragishi A; Keeling JE; Taylor MD
    Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
    Sakoda S; Suzuki T; Higa S; Ueji M; Kishimoto S; Matsumoto M; Yoneda S
    Eur Neurol; 1985; 24(5):330-4. PubMed ID: 3932074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of reverse flow by duplex ultrasonography in orthostatic hypotension.
    Yonehara T; Ando Y; Kimura K; Uchino M; Ando M
    Stroke; 1994 Dec; 25(12):2407-11. PubMed ID: 7974581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy.
    Gibbons CH; Vernino SA; Kaufmann H; Freeman R
    Neurology; 2005 Oct; 65(7):1104-6. PubMed ID: 16217067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effects of oral L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in patients with Shy-Drager syndrome].
    Senda Y; Muto T; Matsuoka Y; Takahashi A; Sobue I
    Rinsho Shinkeigaku; 1987 Mar; 27(3):300-4. PubMed ID: 3111772
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine.
    Carvalho MJ; van den Meiracker AH; Boomsma F; Man in 't Veld AJ; Freitas J; Costa O; de Freitas AF
    J Auton Nerv Syst; 1997 Jan; 62(1-2):63-71. PubMed ID: 9021651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial.
    Freeman R; Landsberg L; Young J
    Neurology; 1999 Dec; 53(9):2151-7. PubMed ID: 10599797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients.
    Iida N; Koshikawa S; Akizawa T; Tsubakihara Y; Marumo F; Akiba T; Kawaguchi Y; Imada A; Yamazaki C; Suzuki M
    Am J Nephrol; 2002; 22(4):338-46. PubMed ID: 12169865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure.
    Kaufmann H; Oribe E; Yahr MD
    J Neural Transm Park Dis Dement Sect; 1991; 3(2):143-8. PubMed ID: 1910486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
    Azuma T; Suzuki T; Mizuno R; Tsujino S; Kishimoto S; Mizuta E; Ichikawa K
    Acta Neurol Scand; 1988 May; 77(5):409-13. PubMed ID: 3137768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.
    Kaufmann H
    Clin Auton Res; 2008 Mar; 18 Suppl 1():19-24. PubMed ID: 18368303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
    Kaufmann H; Saadia D; Voustianiouk A; Goldstein DS; Holmes C; Yahr MD; Nardin R; Freeman R
    Circulation; 2003 Aug; 108(6):724-8. PubMed ID: 12885750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activities in Shy-Drager syndrome.
    Kachi T; Iwase S; Mano T; Saito M; Kunimoto M; Sobue I
    Neurology; 1988 Jul; 38(7):1091-4. PubMed ID: 3133573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute pandysautonomia: mass spectrometric and histopathological studies of the sympathetic nervous system during long term L-threo-3,4-dihydroxyphenylserine treatment.
    Ushiyama M; Ikeda S; Suzuki T; Yazawa M; Yanagisawa N; Tsujino S
    J Neurol Neurosurg Psychiatry; 1996 Jul; 61(1):99-102. PubMed ID: 8676171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of "pure" progressive autonomic failure in an elderly male].
    Kuwahara T; Okura T; Matsumoto S; Dazai Y; Iwata T; Hiwada K
    Nihon Ronen Igakkai Zasshi; 1992 Oct; 29(10):790-3. PubMed ID: 1460785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of cerebral autoregulation in diabetic patients with cardiovascular autonomic neuropathy and orthostatic hypotension.
    Mankovsky BN; Piolot R; Mankovsky OL; Ziegler D
    Diabet Med; 2003 Feb; 20(2):119-26. PubMed ID: 12581263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the noradrenaline precursor, L-threo-3,4-dihydroxyphenylserine, in children with orthostatic intolerance.
    Tanaka H; Yamaguchi H; Mino M
    Clin Auton Res; 1996 Aug; 6(4):189-93. PubMed ID: 8902314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotension.
    Fujisaki K; Kanai H; Hirakata H; Nakamura S; Koga Y; Hattori F; Iida M
    Ther Apher Dial; 2007 Feb; 11(1):49-55. PubMed ID: 17309575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
    Goldstein DS; Holmes C; Kaufmann H; Freeman R
    Clin Auton Res; 2004 Dec; 14(6):363-8. PubMed ID: 15666063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.